Home

Stephen David Prior, Chief Strategy Officer: AN2 Therapeutics ANTX Sell · Filed 01/07

Trade details

Type
Insider sale
Amount
$2,886.58
Shares · price
2,858 sh · $1.01 a share
Held after
59,086 sh
Trade date
26/01/06
Filed
26/01/07
Days to filing
1 days

Sold 4.6% of holdings

Share of holding sold
4.6%

AN2 Therapeutics trades, last 26 weeks

What else happened in AN2 Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/07~02/05

Stephen David Prior's recent trades

  • Stephen David Prior

    SellAN2 Therapeutics

    $3,604

    Filed 01/07

  • Stephen David Prior

    SellAN2 Therapeutics

    $872

    Filed 25/11/06

  • Stephen David Prior

    SellAN2 Therapeutics

    $2,719

    Filed 25/01/07